<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="research-article" xml:lang="en" dtd-version="1.4"><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">BMC Ophthalmol</journal-id><journal-id journal-id-type="iso-abbrev">BMC Ophthalmol</journal-id><journal-id journal-id-type="pmc-domain-id">52</journal-id><journal-id journal-id-type="pmc-domain">bmcopht</journal-id><journal-title-group><journal-title>BMC Ophthalmology</journal-title></journal-title-group><issn pub-type="epub">1471-2415</issn><publisher><publisher-name>BMC</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC12007148</article-id><article-id pub-id-type="pmcid-ver">PMC12007148.1</article-id><article-id pub-id-type="pmcaid">12007148</article-id><article-id pub-id-type="pmcaiid">12007148</article-id><article-id pub-id-type="pmid">40247190</article-id><article-id pub-id-type="doi">10.1186/s12886-025-04062-3</article-id><article-id pub-id-type="publisher-id">4062</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="heading"><subject>Research</subject></subj-group></article-categories><title-group><article-title>Periorbital necrotizing fasciitis: the Manchester experience</article-title></title-group><contrib-group><contrib contrib-type="author"><name name-style="western"><surname>Hopkins</surname><given-names initials="A">Abigail</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Ng</surname><given-names initials="JKY">Jonathan K. Y.</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author" corresp="yes"><name name-style="western"><surname>Ku</surname><given-names initials="JY">Jae Yee</given-names></name><address><email>jku@liverpool.ac.uk</email></address><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Bull</surname><given-names initials="A">Adam</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Pilson</surname><given-names initials="Q">Qistina</given-names></name><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="aff" rid="Aff3">3</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Cook</surname><given-names initials="A">Anne</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/04xtpk854</institution-id><institution-id institution-id-type="GRID">grid.416375.2</institution-id><institution-id institution-id-type="ISNI">0000 0004 0641 2866</institution-id><institution>Manchester Royal Eye Hospital, </institution></institution-wrap>Oxford Road, Manchester, M13 9WL UK </aff><aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/04xs57h96</institution-id><institution-id institution-id-type="GRID">grid.10025.36</institution-id><institution-id institution-id-type="ISNI">0000 0004 1936 8470</institution-id><institution>Department of Eye and Vision Science, </institution><institution>Institute of Life Course and Medical Sciences, Faculty of Health &amp; Life Sciences, University of Liverpool, </institution></institution-wrap>William Henry Duncan Building, 6 West Derby Street, Liverpool, L7 8TX UK </aff><aff id="Aff3"><label>3</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/02dvgss50</institution-id><institution-id institution-id-type="GRID">grid.416626.1</institution-id><institution-id institution-id-type="ISNI">0000 0004 0391 2793</institution-id><institution>Stepping Hill Hospital, Hazel Grove, </institution></institution-wrap>Poplar Grove, Stockport, SK2 7JE UK </aff></contrib-group><pub-date pub-type="epub"><day>17</day><month>4</month><year>2025</year></pub-date><pub-date pub-type="collection"><year>2025</year></pub-date><volume>25</volume><issue-id pub-id-type="pmc-issue-id">478164</issue-id><elocation-id>221</elocation-id><history><date date-type="received"><day>13</day><month>7</month><year>2024</year></date><date date-type="accepted"><day>10</day><month>4</month><year>2025</year></date></history><pub-history><event event-type="pmc-release"><date><day>17</day><month>04</month><year>2025</year></date></event><event event-type="pmc-live"><date><day>18</day><month>04</month><year>2025</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2025-04-19 10:25:14.300"><day>19</day><month>04</month><year>2025</year></date></event></pub-history><permissions><copyright-statement>&#169; The Author(s) 2025</copyright-statement><copyright-year>2025</copyright-year><license><ali:license_ref specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p><bold>Open Access</bold> This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>.</license-p></license></permissions><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="12886_2025_Article_4062.pdf"/><abstract id="Abs1"><sec><title>Background</title><p id="Par1">To describe the presentation and management of patients with periorbital necrotizing fasciitis (PONF) through an observational retrospective case series. The clinical notes of twelve consecutive patients managed by the Oculoplastic and Orbital Service and Maxillofacial Service of the Manchester University NHS Foundation Trust between 2018 and 2023 were reviewed. Five of these patients were contactable and gave informed consent for inclusion in the study.</p></sec><sec><title>Methods</title><p id="Par2">Retrospective review of patient characteristics, risk factors, clinical findings, Laboratory Risk Indicator for Necrotizing Fasciitis (LRINEC) score, imaging results, microbiology and histology results, patient management and mortality.</p></sec><sec><title>Results</title><p id="Par3">The majority of the patients were male (<italic toggle="yes">n</italic>&#8201;=&#8201;3) with a median (IQR) age of 63 (51&#8211;71) years. The median (IQR) number of risk factors per patient was 1 (0&#8211;1.5). All patients had periorbital swelling at presentation. Median (IQR) LRINEC score was 5 (3&#8211;8.5). Group A Streptococcus was isolated from at least one sample (wound swab, tissue sampling, blood culture) in 4 cases. Histology was consistent with PONF in the remaining case. All patients received intravenous antibiotics and had between 1 and 4 surgical debridements. The median (IQR) time from the onset of symptoms to antibiotic treatment was 24 (17&#8211;42) hours, and the time of suspected diagnosis to debridement was 4 (2.3&#8211;6) hours. The median (IQR) final best recorded visual acuity (BRVA) was 2.0 (0.23&#8211;3) logMAR. Three patients developed orbital compartment syndrome; 2 of these had a final BRVA of no perception of light (NPL). The median (IQR) time from the initial surgery to the most recent follow-up was 4 (2.5&#8211;42) months. There was no mortality.</p></sec><sec><title>Conclusions</title><p id="Par4">This study showed no mortality in PONF due to early antibiotic treatment and surgical debridement. A high index of clinical suspicion for PONF using the LRINEC score and other parameters combined with a low threshold for treatment should be maintained, especially in high-risk groups. Urgent referral to specialist surgical teams to ensure prompt diagnosis and treatment is essential to optimise outcomes in the face of this destructive infection.</p></sec></abstract><kwd-group xml:lang="en"><title>Keywords</title><kwd>Periorbital</kwd><kwd>Necrotizing</kwd><kwd>Fasciitis</kwd><kwd>Infection</kwd><kwd>Soft tissues</kwd></kwd-group><funding-group><award-group><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100000836</institution-id><institution>University of Liverpool</institution></institution-wrap></funding-source><award-id>100832880</award-id><principal-award-recipient><name name-style="western"><surname>Ku</surname><given-names>Jae Yee</given-names></name></principal-award-recipient></award-group></funding-group><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>issue-copyright-statement</meta-name><meta-value>&#169; BioMed Central Ltd., part of Springer Nature 2025</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="Sec1"><title>Background</title><p id="Par32">Necrotizing fasciitis (NF) is a rare and severe infection characterised by rapidly spreading necrosis of the soft tissues. Periorbital necrotizing fasciitis (PONF) is a very rare condition with a United Kingdom (UK) incidence of 0.24 cases per million per year [<xref ref-type="bibr" rid="CR1">1</xref>]. The mortality rate from NF is high at 32.3% [<xref ref-type="bibr" rid="CR2">2</xref>], whilst PONF has a lower mortality rate than elsewhere in the body with rates ranging from 3% to 14.4% [<xref ref-type="bibr" rid="CR3">3</xref>&#8211;<xref ref-type="bibr" rid="CR7">7</xref>]. PONF also carries immense morbidity in terms of visual loss, facial deformity, functional and psychological issues long term [<xref ref-type="bibr" rid="CR7">7</xref>, <xref ref-type="bibr" rid="CR8">8</xref>].</p><p id="Par33">Early diagnosis and treatment, including intravenous (IV) antibiotics and surgical debridement, are key in reducing morbidity and mortality [<xref ref-type="bibr" rid="CR4">4</xref>]. However, early signs including swelling, erythema and pain may be similar to other less aggressive soft tissue infections such as preseptal cellulitis. Although rapid progression to extensive necrosis of soft tissues and sepsis is likely to follow, the ambiguous early signs may lead to a delay in diagnosis and poor outcomes. Given this clinical dilemma, Wong et al. developed a novel diagnostic scoring system known as the Laboratory Risk Indicator for Necrotizing Fasciitis (LRINEC) score in 2004 for distinguishing NF from other soft tissue infections. The LRINEC score is based on laboratory tests routinely performed for the evaluation of severe soft tissue infections [<xref ref-type="bibr" rid="CR9">9</xref>]. However, its utility as a predictor in PONF has been debated [<xref ref-type="bibr" rid="CR10">10</xref>].</p><p id="Par34">We present a series of 5 patients with PONF managed by a single, tertiary centre in Manchester, UK, over 5 years. We assessed the predisposing risk factors, presenting signs, laboratory findings, management and outcomes.</p></sec><sec id="Sec2"><title>Methods</title><p id="Par35">Retrospective, observational case series of 5 consecutive patients with histologically confirmed PONF presenting to the Oculoplastics and Orbital Service and Maxillofacial Service of the Manchester University NHS Foundation Trust, UK, over the 5 years (2018&#8211;2023). Data collected included age, gender, date and time of presentation, risk factors (trauma, infection, alcoholism, immunosuppression, recreational drug abuse, concurrent infection, significant medical comorbidities), presenting signs, laboratory findings relevant for the LRINEC score (C reactive protein (CRP), white cell count (WCC), Haemoglobin (Hb), glucose, sodium, creatinine), imaging, management (including antimicrobial and surgical treatment), microbiology and histopathology results. Best recorded visual acuity (BCVA) was measured and reported as logMAR using 2 decimal points, with numeric substitutions of 2.0 and 3.0 for perception of light (PL) and no perception of light (NPL), respectively. All data analyses were performed using Excel (2016) and GraphPad Prism (version 9). Utilising the NHS Health Research Authority decision tool, our study was deemed not to require ethical approval due to its retrospective and observational nature. Informed consent was obtained from all patients.</p></sec><sec id="Sec3"><title>Results</title><sec id="Sec4"><title>Baseline characteristics</title><p id="Par36">Twelve patients with PONF over the specified period were identified, 7 were excluded as they were uncontactable, and therefore we were unable to obtain informed consent for inclusion. 5 patients were included. Most patients were male (3/5; 60%), and they had a median (IQR) age of 63 (51&#8211;71; range 42&#8211;75) years at presentation (Table&#160;<xref rid="Tab1" ref-type="table">1</xref>).
<table-wrap id="Tab1" position="float" orientation="portrait"><label>Table&#160;1</label><caption><p>Patients&#8217; demographics, risk factors, wound, blood culture and tissue biopsy results, Laboratory Risk Indicator for Necrotizing Fasciitis (LRINEC) score and antibiotics therapy</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" colspan="1" rowspan="1">Patient</th><th align="left" colspan="1" rowspan="1">Age</th><th align="left" colspan="1" rowspan="1">Gender</th><th align="left" colspan="1" rowspan="1">Risk Factors</th><th align="left" colspan="1" rowspan="1">Wound Swab Results</th><th align="left" colspan="1" rowspan="1">Blood Culture results</th><th align="left" colspan="1" rowspan="1">Tissue Biopsy Results</th><th align="left" colspan="1" rowspan="1">Antibiotics/anti-viral therapy at presentation</th></tr></thead><tbody><tr><td align="left" colspan="1" rowspan="1">1</td><td align="left" colspan="1" rowspan="1">59</td><td align="left" colspan="1" rowspan="1">M</td><td align="left" colspan="1" rowspan="1">PR3 ANCA positive vasculitis, Type 2 DM</td><td align="left" colspan="1" rowspan="1">NG</td><td align="left" colspan="1" rowspan="1">Gram-positive cocci. NG</td><td align="left" colspan="1" rowspan="1">NF<sup>a</sup></td><td align="left" colspan="1" rowspan="1">Co-amoxiclav, metronidazole</td></tr><tr><td align="left" colspan="1" rowspan="1">2</td><td align="left" colspan="1" rowspan="1">63</td><td align="left" colspan="1" rowspan="1">F</td><td align="left" colspan="1" rowspan="1">Trauma</td><td align="left" colspan="1" rowspan="1">GAS</td><td align="left" colspan="1" rowspan="1">NG</td><td align="left" colspan="1" rowspan="1">NF<sup>a</sup>, GAS</td><td align="left" colspan="1" rowspan="1">Ceftriaxone, clindamycin</td></tr><tr><td align="left" colspan="1" rowspan="1">3</td><td align="left" colspan="1" rowspan="1">42</td><td align="left" colspan="1" rowspan="1">M</td><td align="left" colspan="1" rowspan="1">Nil</td><td align="left" colspan="1" rowspan="1">GAS</td><td align="left" colspan="1" rowspan="1">NG</td><td align="left" colspan="1" rowspan="1">NF<sup>a</sup>, GAS</td><td align="left" colspan="1" rowspan="1">Ceftriaxone, clindamycin</td></tr><tr><td align="left" colspan="1" rowspan="1">4</td><td align="left" colspan="1" rowspan="1">75</td><td align="left" colspan="1" rowspan="1">F</td><td align="left" colspan="1" rowspan="1">Right Herpes Zoster Ophthalmicus</td><td align="left" colspan="1" rowspan="1">GAS</td><td align="left" colspan="1" rowspan="1">NG</td><td align="left" colspan="1" rowspan="1">NF<sup>a</sup>, GAS</td><td align="left" colspan="1" rowspan="1">Ceftriaxone, clindamycin, gentamicin, aciclovir</td></tr><tr><td align="left" colspan="1" rowspan="1">5</td><td align="left" colspan="1" rowspan="1">66</td><td align="left" colspan="1" rowspan="1">M</td><td align="left" colspan="1" rowspan="1">Nil</td><td align="left" colspan="1" rowspan="1">SA</td><td align="left" colspan="1" rowspan="1">NA</td><td align="left" colspan="1" rowspan="1">NF<sup>a</sup>, GAS, SA</td><td align="left" colspan="1" rowspan="1">Ceftriaxone, clindamycin, metronidazole</td></tr></tbody></table><table-wrap-foot><p><italic toggle="yes">DM</italic> Diabetes Mellitus, <italic toggle="yes">NG</italic> No growth, <italic toggle="yes">NA</italic> Not available, <italic toggle="yes">GAS</italic> Group A Streptococcus, <italic toggle="yes">SA</italic> Staphylococcus aureus</p><p><sup>a</sup>Morphological appearances on histology consistent with necrotising fasciitis (NF)</p></table-wrap-foot></table-wrap></p></sec><sec id="Sec5"><title>Risk factors</title><p id="Par37">The median (IQR) number of risk factors per patient was 1 (0&#8211;1.5; range 0&#8211;2) (Table&#160;<xref rid="Tab1" ref-type="table">1</xref>). Trauma was identified as a risk factor in one case. One patient was immunosuppressed on oral prednisolone for PR3-ANCA positive vasculitis, and one patient had suspected preceding right-sided Herpes Zoster Ophthalmicus (HZO) infection. Two patients were found to have no risk factors for PONF.</p></sec><sec id="Sec6"><title>Clinical findings at presentation</title><p id="Par38">All patients had unilateral periorbital swelling at presentation (4 right side, 1 left side). Three patients had significant sloughing of periocular tissue and skin breakdown. Two patients (patients 3 and 5) presented with orbital compartment syndrome with raised intraocular pressures (IOP) and a relative afferent pupillary defect (RAPD). Patient 3 presented with BRVA of NPL, while patient 5 presented with BRVA of PL. BRVA at presentation was measured in 60% (3/5) of the cases. In cases where vision was not documented, this was due to the clinician&#8217;s inability to open the eye (despite the assistance of Desmarres retractors) due to substantial periocular swelling. Where BRVA at presentation was obtainable, it ranged from 1.0 logMAR to NPL.</p></sec><sec id="Sec7"><title>Laboratory findings/LRINEC</title><p id="Par39">Data contributing to the LRINEC score were available in all patients. At presentation, median (IQR) CRP was 220.5 (47.1&#8211;340.3; range 10.5&#8211;359) mg/L, WCC 18.2 (12.3&#8211;31.5; range 11.4&#8211;34.9&#8201;&#215;&#8201;10/uL), Hb 138 (121&#8211;147.5; range 116&#8211;150) g/l, glucose 7.6 (6.4&#8211;7.8; range 6.4&#8211;7.8) mmol/L, sodium 137.5 (132.5&#8211;138.8; range 131&#8211;139) mmol/L and creatinine 76.5 (56.8&#8211;103; range 54&#8211;108) mg/dl. Median (IQR) LRINEC score was 5 (2&#8211;7.3; range 1&#8211;8), and 2 patients had a score of 7 or greater.</p></sec><sec id="Sec8"><title>Imaging results</title><p id="Par40">Computerised tomography (CT) imaging of the head and orbits was undertaken in all patients at presentation. Results showed soft tissue swelling in the periorbital region in all cases. The soft tissue inflammatory changes appeared to be pre-septal in 3 cases and post-septal in 2 cases. Intra-orbital gas was not noted in any of the cases included in this study.</p><p id="Par41">On CT imaging, patient 3 was found to have soft tissue thickening in the superior and lateral aspect of the orbit, displacing the orbital structures inferiorly (Fig.&#160;<xref rid="Fig1" ref-type="fig">1</xref>). It was deemed that these findings were likely to represent infection. He had no well-defined intraorbital fluid collection and no underlying sinusitis.<fig id="Fig1" position="float" orientation="portrait"><label>Fig.&#160;1</label><caption><p>CT scan of patient 3 at presentation&#160;showing soft tissue thickening in the superior and lateral aspect of the left orbit, displacing the orbital structures inferiorly, shown in the coronal (<bold>A</bold>) and axial (<bold>B</bold>) sections</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="MO1" position="float" orientation="portrait" xlink:href="12886_2025_4062_Fig1_HTML.jpg"/></fig></p></sec><sec id="Sec9"><title>Microbiology and histology results</title><p id="Par42">Wound swabs and tissue sampling were undertaken in all patients (Table&#160;<xref rid="Tab1" ref-type="table">1</xref>). Peripheral blood cultures were taken in 4 patients. Group A Streptococcus was isolated from wound swabs in 3 cases, tissue samples in 4 cases and no blood cultures. Group A Streptococcus was isolated from at least 1 sample in 4 cases. In the remaining case (Patient 1), although Gram, Grocott and PAS stains were negative for microorganisms, the overall morphological appearances on histopathology were consistent with NF.</p></sec><sec id="Sec10"><title>Antimicrobial treatment</title><p id="Par43">At presentation, all patients received IV antibiotics. The choice of initial antimicrobial therapy at presentation was variable (Table&#160;<xref rid="Tab1" ref-type="table">1</xref>). The time from patient-reported onset of symptoms to treatment with antibiotics was available in all cases (median 24, IQR 17&#8211;42, range 10&#8211;48 h) (Table&#160;<xref rid="Tab2" ref-type="table">2</xref>). Two patients received a combination of IV ceftriaxone and clindamycin only. The remaining 3 patients received various combinations of IV antibiotics including co-amoxiclav (<italic toggle="yes">n</italic>&#8201;=&#8201;1), metronidazole (<italic toggle="yes">n</italic>&#8201;=&#8201;1), clindamycin (<italic toggle="yes">n</italic>&#8201;=&#8201;2), gentamicin (<italic toggle="yes">n</italic>&#8201;=&#8201;1) and ceftriaxone (<italic toggle="yes">n</italic>&#8201;=&#8201;2). One patient was also commenced on IV aciclovir due to a suspected herpes zoster infection.
<table-wrap id="Tab2" position="float" orientation="portrait"><label>Table&#160;2</label><caption><p>Patients&#8217; best recorded visual acuity (BRVA), time to treatments, number of debridements, complications, reconstructive procedures and follow-up duration</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" colspan="1" rowspan="1">Patient</th><th align="left" colspan="1" rowspan="1">Laterality</th><th align="left" colspan="1" rowspan="1">BRVA at presentation (logMAR)</th><th align="left" colspan="1" rowspan="1">Final BRVA (logMAR)</th><th align="left" colspan="1" rowspan="1">Onset of symptoms to antibiotic therapy (hours)</th><th align="left" colspan="1" rowspan="1">Clinical diagnosis PONF to surgery (hours)</th><th align="left" colspan="1" rowspan="1">Number of debridement(s)</th><th align="left" colspan="1" rowspan="1">Complications</th><th align="left" colspan="1" rowspan="1">Initial surgery to last follow-up (months)</th><th align="left" colspan="1" rowspan="1">Reconstructive procedures</th></tr></thead><tbody><tr><td align="left" colspan="1" rowspan="1">1</td><td align="left" colspan="1" rowspan="1">Right</td><td align="left" colspan="1" rowspan="1">UO</td><td align="left" colspan="1" rowspan="1">0.1</td><td align="left" colspan="1" rowspan="1">10.0</td><td align="left" colspan="1" rowspan="1">2.5</td><td align="left" colspan="1" rowspan="1">3</td><td align="left" colspan="1" rowspan="1">Lagophthalmos, Ectropion</td><td align="left" colspan="1" rowspan="1">32</td><td align="left" colspan="1" rowspan="1">Right upper and lower lid integra graft, right upper lid FTSG</td></tr><tr><td align="left" colspan="1" rowspan="1">2</td><td align="left" colspan="1" rowspan="1">Right</td><td align="left" colspan="1" rowspan="1">1.0</td><td align="left" colspan="1" rowspan="1">NPL</td><td align="left" colspan="1" rowspan="1">24.0</td><td align="left" colspan="1" rowspan="1">4.0</td><td align="left" colspan="1" rowspan="1">4</td><td align="left" colspan="1" rowspan="1">OCS<sup>a</sup>, Lagophthalmos, EK</td><td align="left" colspan="1" rowspan="1">51</td><td align="left" colspan="1" rowspan="1">Temporalis flap, right upper lid SSG, right upper lid revision with orbicularis flap and skin graft, right upper lid skin/orbicularis transposition flap</td></tr><tr><td align="left" colspan="1" rowspan="1">3</td><td align="left" colspan="1" rowspan="1">Left</td><td align="left" colspan="1" rowspan="1">NPL</td><td align="left" colspan="1" rowspan="1">NPL</td><td align="left" colspan="1" rowspan="1">23.0</td><td align="left" colspan="1" rowspan="1">2.0</td><td align="left" colspan="1" rowspan="1">4</td><td align="left" colspan="1" rowspan="1">OCS<sup>b</sup>, Lagophthalmos, EK</td><td align="left" colspan="1" rowspan="1">4</td><td align="left" colspan="1" rowspan="1">Left upper lid integra graft followed by FTSG</td></tr><tr><td align="left" colspan="1" rowspan="1">4</td><td align="left" colspan="1" rowspan="1">Right</td><td align="left" colspan="1" rowspan="1">UO</td><td align="left" colspan="1" rowspan="1">0.36</td><td align="left" colspan="1" rowspan="1">48.0</td><td align="left" colspan="1" rowspan="1">8.0</td><td align="left" colspan="1" rowspan="1">1</td><td align="left" colspan="1" rowspan="1">Lagophthalmos, EK</td><td align="left" colspan="1" rowspan="1">1</td><td align="left" colspan="1" rowspan="1">Right lateral orbital orbicularis propeller flap</td></tr><tr><td align="left" colspan="1" rowspan="1">5</td><td align="left" colspan="1" rowspan="1">Right</td><td align="left" colspan="1" rowspan="1">PL</td><td align="left" colspan="1" rowspan="1">PL</td><td align="left" colspan="1" rowspan="1">36.0</td><td align="left" colspan="1" rowspan="1">4.0</td><td align="left" colspan="1" rowspan="1">2</td><td align="left" colspan="1" rowspan="1">OCS<sup>b</sup></td><td align="left" colspan="1" rowspan="1">0</td><td align="left" colspan="1" rowspan="1">Right upper and lower lid integra graft, right upper and lower lid SSG</td></tr></tbody></table><table-wrap-foot><p><italic toggle="yes">PONF</italic> Periorbital necrotizing fasciitis, <italic toggle="yes">UO</italic> Unable to open, <italic toggle="yes">PL</italic> Perception of Light, <italic toggle="yes">NPL</italic> No perception of light, <italic toggle="yes">OCS</italic> Orbital compartment syndrome, <italic toggle="yes">EK</italic>&#160;Exposure keratopathy, <italic toggle="yes">SSG</italic>&#160;Split thickness skin graft, <italic toggle="yes">FTSG</italic>&#160;Full thickness skin graft</p><p><sup>a</sup>Post operative OCS</p><p><sup>b</sup>OCS&#160;at presentation</p></table-wrap-foot></table-wrap></p></sec><sec id="Sec11"><title>Surgical management</title><p id="Par44">All patients underwent surgical debridement with a multi-disciplinary team approach. The maxillofacial team was involved in 4 cases, and the Ear, Nose and Throat (ENT) team was involved in 2 cases. The time from clinical diagnosis of PONF to the first debridement was recorded in all 5 cases with a median (IQR) of 4 (2.3&#8211;6; range 2&#8211;8) hours. Patients underwent between 1 and 4 surgical debridements (median 3, IQR 1.5&#8211;4). In all cases, necrotic tissue was described intraoperatively, and debridement down to healthy bleeding tissue was achieved.</p><p id="Par45">All patients required further reconstructive procedures (Table&#160;<xref rid="Tab2" ref-type="table">2</xref>). Skin grafting was involved in reconstruction in 4 cases. Pre and post-operative images from patients 2, 3 and 4 are shown in Figs.&#160;<xref rid="Fig2" ref-type="fig">2</xref>, <xref rid="Fig3" ref-type="fig">3</xref> and <xref rid="Fig4" ref-type="fig">4</xref>, respectively.<fig id="Fig2" position="float" orientation="portrait"><label>Fig.&#160;2</label><caption><p>Patient 2 at presentation showed right-sided dusky peri-orbital erythema, necrosis and sloughing of right upper eyelid skin (<bold>A</bold>), and at their most recent follow-up, following debridement and reconstruction, where there is apparent&#160;right upper lid tissue loss (<bold>B</bold>)</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="MO2" position="float" orientation="portrait" xlink:href="12886_2025_4062_Fig2_HTML.jpg"/></fig><fig id="Fig3" position="float" orientation="portrait"><label>Fig.&#160;3</label><caption><p>Patient 3 prior to their first debridement showed significant left-sided peri-orbital swelling (<bold>A</bold>), before their third exploration and debridement showing the extent of debrided tissues with tarsorrhaphy and drain in situ (<bold>B</bold>) and at their most recent follow-up following debridement and reconstruction showing slight thickening of the upper lid graft and hypoglobus (<bold>C</bold>)</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="MO3" position="float" orientation="portrait" xlink:href="12886_2025_4062_Fig3_HTML.jpg"/></fig><fig id="Fig4" position="float" orientation="portrait"><label>Fig.&#160;4</label><caption><p>Patient 4 at presentation showed right-sided slightly dusky peri-orbital erythema with sloughing of upper lid tissue (<bold>A</bold>). At their most recent follow-up, following debridement and reconstruction, showed slight thickening and contracture of the flap with medial webbing (<bold>B</bold>)</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="MO4" position="float" orientation="portrait" xlink:href="12886_2025_4062_Fig4_HTML.jpg"/></fig></p></sec><sec id="Sec12"><title>Post-operative / follow-up</title><p id="Par46">The median (IQR) time from initial surgery to their most recent follow-up was 4 (2.5&#8211;42; range 1&#8211;51) months (Table&#160;<xref rid="Tab2" ref-type="table">2</xref>). The median (IQR) final BRVA (BRVA at their most recent follow-up) was 2 (IQR 0.23&#8211;3, range 0.10&#8211;3.0) logMAR. Patient 2 developed post-op orbital compartment syndrome following their first debridement. This patient underwent urgent canthotomy and cantholysis, followed by urgent orbital exploration and medial wall decompression along with further debridement. In this case, the final BRVA did not improve from NPL, and there was significant upper lid tissue loss and lagophthalmos (Fig.&#160;<xref rid="Fig2" ref-type="fig">2</xref>).</p><p id="Par47">Most patients (80.0%; 4/5) had some degree of lagophthalmos at their most recent follow-up, and 60% (3/5) had evidence of exposure keratopathy. No patients required evisceration or enucleation. The mortality rate amongst the studied cohort was 0%.</p></sec></sec><sec id="Sec13"><title>Discussion</title><p id="Par48">Risk factors for the development of PONF include, but are not limited to, trauma, recent surgery, co-existing infection, alcoholism, drug abuse, diabetes, rheumatological disease, chemotherapy, immunosuppression, malignancy, renal failure and systemic malignancy [<xref ref-type="bibr" rid="CR7">7</xref>]. In our series, most patients had at least one risk factor for the development of the disease.</p><p id="Par49">It is well recognised that drug or alcohol misuse predisposes patients to the development of necrotising fasciitis. Unfortunately, due to issues tracing patients from this cohort to obtain informed consent, 5 patients with a history of drug or alcohol misuse had to be excluded from the study. A study by Yii et al. examined the relationship between alcohol intake and infection with NF. The study found that the incidence of NF in alcohol misuse disorder was nearly 7.73 times higher than in controls [<xref ref-type="bibr" rid="CR11">11</xref>]. A number of theories exist to explain this correlation. First, chronic, heavy consumption of alcohol affects numerous components of the immune system, ultimately causing immunosuppression, leading to increased susceptibility to all types of infection [<xref ref-type="bibr" rid="CR12">12</xref>]. One study suggested that increased alcohol exposure is associated with poor wound healing and increased susceptibility to Group A Streptococcal infection [<xref ref-type="bibr" rid="CR13">13</xref>]. In addition, studies have shown that intoxication with alcohol significantly increases the risk of trauma and hence soft tissue injury, therefore increasing the risk of development of secondary infection [<xref ref-type="bibr" rid="CR14">14</xref>, <xref ref-type="bibr" rid="CR15">15</xref>]. Alcoholism is known to be associated with early self-discharge and poor compliance with treatment advice [<xref ref-type="bibr" rid="CR11">11</xref>, <xref ref-type="bibr" rid="CR16">16</xref>, <xref ref-type="bibr" rid="CR17">17</xref>]. Delays in receiving appropriate treatment for PONF are likely to lead to more rapid progression, increased severity of disease, more intensive management and higher rates of morbidity and mortality. This association between drug and alcohol misuse and PONF is not accurately portrayed in this study due to patient tracing issues.</p><p id="Par50">The majority of patients in our cohort presented with a short history of unilateral periocular swelling. Periocular swelling is a common, non-specific symptom which may be associated with many less serious infective conditions, such as pre-septal cellulitis. Given the severity of the swelling in our cohort, the differential diagnosis in most patients was orbital cellulitis, and urgent Ophthalmology input was sought. Early commencement of antimicrobial therapy for probable orbital cellulitis was common and preceded the clinical diagnosis of PONF in all cases. In most cases, clinical diagnosis of PONF was delayed until the patient was referred and transferred from the presenting trust to our centre for ophthalmic assessment, which caused a delay in diagnosis and appropriate management for PONF.</p><p id="Par51">Patient 4 of this case series (Table&#160;<xref rid="Tab1" ref-type="table">1</xref>) presented to a different centre with unilateral periocular swelling and scab-like lesions in the periocular region (Fig.&#160;<xref rid="Fig4" ref-type="fig">4</xref>). She was initially treated for HZO for around 12 h, followed by a rapid increase in periocular swelling and systemic deterioration with the development of sepsis. Several cases of NF following Herpes Zoster infection have been reported [<xref ref-type="bibr" rid="CR18">18</xref>&#8211;<xref ref-type="bibr" rid="CR23">23</xref>]. Unfortunately, at the centre to which she presented, patient 4 had no microbiological testing at the onset of the initial vesicular rash, and no viral Polymerase Chain Reaction (PCR) was sent as the disease progressed. It remains unclear if the presumed preceding viral infection led to the development of PONF or if there was a misdiagnosis at presentation. This patient was not known to be immunosuppressed. She only required 1 surgical debridement and 1 reconstructive procedure.</p><p id="Par52">Given the issues mentioned previously regarding the ambiguous signs and symptoms of PONF, the LRINEC score developed by Wong et al. to distinguish NF from other soft tissue infections has been applied to diagnose PONF [<xref ref-type="bibr" rid="CR9">9</xref>]. However, the LRINEC score was developed based on a retrospective observational study, and it was not designed specifically for diagnosing PONF. Tambe et al. found that in their case series of 11 patients with PONF, the LRINEC score did not correlate with disease severity [<xref ref-type="bibr" rid="CR10">10</xref>].</p><p id="Par53">In this case series, we found that there was incomplete LRINEC scoring data, with a missing glucose value in 1 of our cases. Patient 3 had a low score of 1 despite a confirmed diagnosis of PONF. Since the LRINEC score is considered unreliable in this setting [<xref ref-type="bibr" rid="CR10">10</xref>], the calculation of the LRINEC score at presentation should be used only as an aid to the diagnosis of suspected PONF and interpreted with caution. The score must be coupled with a careful review of suggestive clinical signs and symptoms, and any suspicion of PONF should still trigger an urgent Ophthalmology review.</p><p id="Par54">Previous studies have also advocated the use of CT scanning to support the diagnosis of PONF [<xref ref-type="bibr" rid="CR4">4</xref>, <xref ref-type="bibr" rid="CR7">7</xref>]. Signs of NF on CT scanning include fascial thickening, fat stranding, gas tracking along fascial planes and abscesses [<xref ref-type="bibr" rid="CR4">4</xref>, <xref ref-type="bibr" rid="CR24">24</xref>&#8211;<xref ref-type="bibr" rid="CR26">26</xref>]. With none of our cases demonstrating gas on their initial CT scan, our results suggest that gas on the CT scan may not be a sensitive marker of PONF. CT scanning, however, is still useful in cases of suspected severe periocular infection to assess the extent of the infection and assist in surgical planning [<xref ref-type="bibr" rid="CR27">27</xref>].</p><p id="Par55">It is well-recognised that PONF has a more favourable mortality rate than the same infection elsewhere in the body [<xref ref-type="bibr" rid="CR28">28</xref>]. It has been postulated that the reason for the superior prognosis in PONF is the earlier presentation, given that the periocular region is highly visible, and swelling may lead to a reduction in vision. Secondly, antibiotics may have improved penetration to the periocular area, given the extensive blood supply of this region. This may result in more rapid uptake by tissues surrounding the necrotic areas, leading to slower dissemination of the infection. Finally, the orbital septal integrity may prevent or delay posterior orbital spread following pre-septal infection [<xref ref-type="bibr" rid="CR3">3</xref>]. In our study, we found a mortality rate of 0%, which was lower than that of some similar UK studies [<xref ref-type="bibr" rid="CR1">1</xref>, <xref ref-type="bibr" rid="CR3">3</xref>]. This observation may be related to the fact that a number of patients with multiple risk factors, including trauma and drug or alcohol misuse, were excluded from the study as they were uncontactable to provide consent, leaving a potentially healthier cohort with fewer comorbidities.</p><p id="Par56">The final visual outcome in our cohort was variable. Two patients had a final BRVA of 0.36 logMAR or better, while 3 eyes had final visual acuity of PL or NPL secondary to orbital compartment syndrome. The development of orbital compartment syndrome secondary to PONF is not well documented in the literature. Given our findings, it is pertinent that patients should be closely monitored for this specific complication during the disease course. Pronounced periocular swelling with a tense orbit, indicative of orbital compartment syndrome, is an ophthalmic emergency and requires urgent diagnosis and management with a canthotomy and cantholysis to preserve sight. Ophthalmologists and other front-line health care professionals should recognise this complication and perform a canthotomy and cantholysis urgently to preserve sight.</p><p id="Par57">All our patients received IV antibiotics and underwent surgical debridement. Many patients had multiple debridements (range 1&#8211;4). While it is not possible to determine if antibiotics or surgical debridement alone leads to a better outcome, most studies use a combination of both [<xref ref-type="bibr" rid="CR3">3</xref>, <xref ref-type="bibr" rid="CR7">7</xref>, <xref ref-type="bibr" rid="CR10">10</xref>]. In this series, we noted much variability in antimicrobial therapy commenced at presentation. There are a number of reasons for this lack of consistency. In most cases, antibiotics were commenced at peripheral units prior to the patient being transferred to our tertiary centre for ongoing management. At these units, there are likely to be different guidelines in place for antimicrobial treatment. In addition, diagnostic uncertainty is likely to lead to inconsistency in antimicrobial prescription. As we have previously discussed, PONF is often misdiagnosed as orbital cellulitis. In many cases, initial antimicrobial treatment was presumably targeted towards this diagnosis. Our local microbiology guideline advises IV meropenem, clindamycin and gentamicin and discussion with a consultant microbiologist for suspected cases of PONF. On transfer to our centre, all cases were discussed with our local microbiology team for expert advice and antibiotic treatment was appropriately modified on an individualised basis depending upon current and previous antibiotic usage, patient allergies and available microbiology results. In cases of suspected PONF, appropriate broad-spectrum antibiotic therapy is paramount [<xref ref-type="bibr" rid="CR7">7</xref>]. The variability in antimicrobial prophylaxis in our series highlights the need for a robust antimicrobial guideline which all clinicians are aware of and can refer to for suspected PONF cases.</p><p id="Par58">Given the necrotic nature of NF, a combination of antimicrobial therapy and early debridement, instead of antimicrobial therapy alone, is likely to improve patient outcomes as antibiotic penetration into necrotic tissues may be limited. Therefore, previous studies have historically advocated early and extensive debridement down to healthy tissue in cases of PONF [<xref ref-type="bibr" rid="CR4">4</xref>, <xref ref-type="bibr" rid="CR7">7</xref>]. More recent studies suggest that antibiotic therapy alone may offer comparable results in terms of morbidity and mortality [<xref ref-type="bibr" rid="CR3">3</xref>, <xref ref-type="bibr" rid="CR29">29</xref>, <xref ref-type="bibr" rid="CR30">30</xref>]. However, the evidence here remains limited, and this approach should be taken with much caution.</p><p id="Par59">We are aware of reports of adjunctive use of IV immunoglobulin in PONF [<xref ref-type="bibr" rid="CR31">31</xref>]. However, as evidence for its efficacy is lacking, IV immunoglobulin was not used as a treatment modality in our cohort. Adjunctive steroid was also not utilised in our patient cohort.</p></sec><sec id="Sec14"><title>Conclusion</title><p id="Par60">In conclusion, this study showed no mortality in PONF due to early antibiotic treatment and surgical debridement. A high index of clinical suspicion for PONF using the LRINEC score and other parameters combined with a low threshold for treatment should be maintained, especially in high-risk groups. Urgent referral to specialist surgical teams to ensure prompt diagnosis and treatment is essential to optimise outcomes in the face of this destructive infection.</p></sec></body><back><glossary><title>Abbreviations</title><def-list><def-item><term>PONF</term><def><p id="Par5">Periorbital necrotizing fasciitis</p></def></def-item><def-item><term>BRVA</term><def><p id="Par6">Best recorded visual acuity</p></def></def-item><def-item><term>LRINEC</term><def><p id="Par7">Laboratory Risk Indicator for Necrotizing Fasciitis</p></def></def-item><def-item><term>PL</term><def><p id="Par8">Perception of light</p></def></def-item><def-item><term>NPL</term><def><p id="Par9">No perception of light</p></def></def-item><def-item><term>NF</term><def><p id="Par10">Necrotizing fasciitis</p></def></def-item><def-item><term>IV</term><def><p id="Par11">Intravenous</p></def></def-item><def-item><term>CRP</term><def><p id="Par12">C reactive protein</p></def></def-item><def-item><term>WCC</term><def><p id="Par13">White cell count</p></def></def-item><def-item><term>Hb</term><def><p id="Par14">Haemoglobin</p></def></def-item><def-item><term>UK</term><def><p id="Par15">United Kingdom</p></def></def-item><def-item><term>RAPD</term><def><p id="Par16">Relative afferent pupillary defect</p></def></def-item><def-item><term>IOP</term><def><p id="Par17">Intraocular pressure</p></def></def-item><def-item><term>PCR</term><def><p id="Par18">Polymerase chain reaction</p></def></def-item><def-item><term>CT</term><def><p id="Par19">Computerised tomography</p></def></def-item><def-item><term>HZO</term><def><p id="Par20">Herpes zoster ophthalmicus</p></def></def-item><def-item><term>OCS</term><def><p id="Par21">Orbital compartment syndrome</p></def></def-item><def-item><term>EK</term><def><p id="Par22">Exposure Keratopathy</p></def></def-item><def-item><term>DM</term><def><p id="Par23">Diabetes mellitus</p></def></def-item><def-item><term>GAS</term><def><p id="Par24">Group A Streptococcus</p></def></def-item><def-item><term>SA</term><def><p id="Par25">Staphylococcus aureus</p></def></def-item><def-item><term>NG</term><def><p id="Par26">No growth</p></def></def-item><def-item><term>NA</term><def><p id="Par27">Not available</p></def></def-item><def-item><term>SSG</term><def><p id="Par28">Split-thickness skin graft</p></def></def-item><def-item><term>FTSG</term><def><p id="Par29">Full Thickness Skin Graft</p></def></def-item><def-item><term>UO</term><def><p id="Par30">Unable to Open</p></def></def-item><def-item><term>ENT</term><def><p id="Par31">Ear Nose and Throat</p></def></def-item></def-list></glossary><fn-group><fn><p><bold>Publisher&#8217;s Note</bold></p><p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></fn></fn-group><ack><title>Acknowledgements</title><p>Not applicable.</p></ack><notes notes-type="author-contribution"><title>Authors&#8217; contributions</title><p>Conception and design: Hopkins, Ng, Bull, Cook Data acquisition: Hopkins, Ng, Bull, Pilson, Cook Data analysis and interpretation: Hopkins, Ng, Ku Manuscript drafting and revisions: Hopkins, Ng, Ku, Bull, Cook Final approval of manuscript: Hopkins, Ng, Ku, Bull, Pilson, Cook.</p></notes><notes notes-type="funding-information"><title>Funding</title><p>No financial support.</p></notes><notes notes-type="data-availability"><title>Data availability</title><p>All data analysed in the current study are included in this article (presented in Tables <xref rid="Tab1" ref-type="table">1</xref> and <xref rid="Tab2" ref-type="table">2</xref>).</p></notes><notes><title>Declarations</title><notes id="FPar1"><title>Ethics approval and consent to participate</title><p id="Par61">The NHS Health Research Authority study tool was used to confirm that this study is not considered research, therefore, ethics approval was not deemed necessary. (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.hra-decisiontools.org.uk/research/">https://www.hra-decisiontools.org.uk/research/</ext-link>). This study was conducted in accordance with the Declaration of Helsinki and the UK&#8217;s Data Protection Act 2018. Informed consent has been obtained from all patients.</p></notes><notes id="FPar2"><title>Consent for publication</title><p id="Par62">All patient information included in the study has been anonymised except clinical photographs. Written informed consent was obtained from all patients included in this series.</p></notes><notes id="FPar3" notes-type="COI-statement"><title>Competing interests</title><p id="Par63">The authors declare no competing interests.</p></notes></notes><ref-list id="Bib1"><title>References</title><ref id="CR1"><label>1.</label><citation-alternatives><element-citation id="ec-CR1" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Flavahan</surname><given-names>PW</given-names></name><name name-style="western"><surname>Cauchi</surname><given-names>P</given-names></name><name name-style="western"><surname>Gregory</surname><given-names>ME</given-names></name><name name-style="western"><surname>Foot</surname><given-names>B</given-names></name><name name-style="western"><surname>Drummond</surname><given-names>SR</given-names></name></person-group><article-title>Incidence of periorbital necrotising fasciitis in the UK population: a BOSU study</article-title><source>Br J Ophthalmol</source><year>2014</year><volume>98</volume><issue>9</issue><fpage>1177</fpage><lpage>1180</lpage><pub-id pub-id-type="doi">10.1136/bjophthalmol-2013-304735</pub-id><pub-id pub-id-type="pmid">25136080</pub-id></element-citation><mixed-citation id="mc-CR1" publication-type="journal">Flavahan PW, Cauchi P, Gregory ME, Foot B, Drummond SR. Incidence of periorbital necrotising fasciitis in the UK population: a BOSU study. Br J Ophthalmol. 2014;98(9):1177&#8211;80.<pub-id pub-id-type="pmid">25136080</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1136/bjophthalmol-2013-304735</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR2"><label>2.</label><citation-alternatives><element-citation id="ec-CR2" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Misiakos</surname><given-names>EP</given-names></name><name name-style="western"><surname>Bagias</surname><given-names>G</given-names></name><name name-style="western"><surname>Patapis</surname><given-names>P</given-names></name><name name-style="western"><surname>Sotiropoulos</surname><given-names>D</given-names></name><name name-style="western"><surname>Kanavidis</surname><given-names>P</given-names></name><name name-style="western"><surname>Machairas</surname><given-names>A</given-names></name></person-group><article-title>Current concepts in the management of necrotizing fasciitis</article-title><source>Front Surg</source><year>2014</year><volume>29</volume><issue>1</issue><fpage>36</fpage><pub-id pub-id-type="doi" assigning-authority="pmc">10.3389/fsurg.2014.00036</pub-id><pub-id pub-id-type="pmcid">PMC4286984</pub-id><pub-id pub-id-type="pmid">25593960</pub-id></element-citation><mixed-citation id="mc-CR2" publication-type="journal">Misiakos EP, Bagias G, Patapis P, Sotiropoulos D, Kanavidis P, Machairas A. Current concepts in the management of necrotizing fasciitis. Front Surg. 2014;29(1):36.<pub-id pub-id-type="doi" assigning-authority="pmc">10.3389/fsurg.2014.00036</pub-id><pub-id pub-id-type="pmcid">PMC4286984</pub-id><pub-id pub-id-type="pmid">25593960</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR3"><label>3.</label><citation-alternatives><element-citation id="ec-CR3" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rajak</surname><given-names>SN</given-names></name><name name-style="western"><surname>Figueira</surname><given-names>EC</given-names></name><name name-style="western"><surname>Haridas</surname><given-names>AS</given-names></name><name name-style="western"><surname>Satchi</surname><given-names>K</given-names></name><name name-style="western"><surname>Uddin</surname><given-names>JM</given-names></name><name name-style="western"><surname>McNab</surname><given-names>AA</given-names></name><name name-style="western"><surname>Rene</surname><given-names>C</given-names></name><name name-style="western"><surname>Sullivan</surname><given-names>TJ</given-names></name><name name-style="western"><surname>Rose</surname><given-names>GE</given-names></name><name name-style="western"><surname>Selva</surname><given-names>D</given-names></name></person-group><article-title>Periocular necrotising fasciitis: a multicentre case series</article-title><source>Br J Ophthalmol</source><year>2016</year><volume>100</volume><issue>11</issue><fpage>1517</fpage><lpage>1520</lpage><pub-id pub-id-type="doi">10.1136/bjophthalmol-2015-307445</pub-id><pub-id pub-id-type="pmid">26837505</pub-id></element-citation><mixed-citation id="mc-CR3" publication-type="journal">Rajak SN, Figueira EC, Haridas AS, Satchi K, Uddin JM, McNab AA, Rene C, Sullivan TJ, Rose GE, Selva D. Periocular necrotising fasciitis: a multicentre case series. Br J Ophthalmol. 2016;100(11):1517&#8211;20.<pub-id pub-id-type="pmid">26837505</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1136/bjophthalmol-2015-307445</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR4"><label>4.</label><citation-alternatives><element-citation id="ec-CR4" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lazzeri</surname><given-names>D</given-names></name><name name-style="western"><surname>Lazzeri</surname><given-names>S</given-names></name><name name-style="western"><surname>Figus</surname><given-names>M</given-names></name><name name-style="western"><surname>Tascini</surname><given-names>C</given-names></name><name name-style="western"><surname>Bocci</surname><given-names>G</given-names></name><name name-style="western"><surname>Colizzi</surname><given-names>L</given-names></name><name name-style="western"><surname>Giannotti</surname><given-names>G</given-names></name><name name-style="western"><surname>Lorenzetti</surname><given-names>F</given-names></name><name name-style="western"><surname>Gandini</surname><given-names>D</given-names></name><name name-style="western"><surname>Danesi</surname><given-names>R</given-names></name><name name-style="western"><surname>Menichetti</surname><given-names>F</given-names></name></person-group><article-title>Periorbital necrotising fasciitis</article-title><source>Br J Ophthalmol</source><year>2010</year><volume>94</volume><issue>12</issue><fpage>1577</fpage><lpage>1585</lpage><pub-id pub-id-type="doi">10.1136/bjo.2009.167486</pub-id><pub-id pub-id-type="pmid">19897473</pub-id></element-citation><mixed-citation id="mc-CR4" publication-type="journal">Lazzeri D, Lazzeri S, Figus M, Tascini C, Bocci G, Colizzi L, Giannotti G, Lorenzetti F, Gandini D, Danesi R, Menichetti F. Periorbital necrotising fasciitis. Br J Ophthalmol. 2010;94(12):1577&#8211;85.<pub-id pub-id-type="pmid">19897473</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1136/bjo.2009.167486</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR5"><label>5.</label><citation-alternatives><element-citation id="ec-CR5" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kronish</surname><given-names>JW</given-names></name><name name-style="western"><surname>McLeish</surname><given-names>WM</given-names></name></person-group><article-title>Eyelid necrosis and periorbital necrotizing fasciitis: report of a case and review of the literature</article-title><source>Ophthalmology</source><year>1991</year><volume>98</volume><issue>1</issue><fpage>92</fpage><lpage>98</lpage><pub-id pub-id-type="doi">10.1016/S0161-6420(91)32334-0</pub-id><pub-id pub-id-type="pmid">2023741</pub-id></element-citation><mixed-citation id="mc-CR5" publication-type="journal">Kronish JW, McLeish WM. Eyelid necrosis and periorbital necrotizing fasciitis: report of a case and review of the literature. Ophthalmology. 1991;98(1):92&#8211;8.<pub-id pub-id-type="pmid">2023741</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/s0161-6420(91)32334-0</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR6"><label>6.</label><citation-alternatives><element-citation id="ec-CR6" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Elner</surname><given-names>VM</given-names></name><name name-style="western"><surname>Demirci</surname><given-names>H</given-names></name><name name-style="western"><surname>Nerad</surname><given-names>JA</given-names></name><name name-style="western"><surname>Hassan</surname><given-names>AS</given-names></name></person-group><article-title>Periocular necrotizing fasciitis with visual loss: pathogenesis and treatment</article-title><source>Ophthalmology</source><year>2006</year><volume>113</volume><issue>12</issue><fpage>2338</fpage><lpage>2345</lpage><pub-id pub-id-type="doi">10.1016/j.ophtha.2006.06.037</pub-id><pub-id pub-id-type="pmid">16996594</pub-id></element-citation><mixed-citation id="mc-CR6" publication-type="journal">Elner VM, Demirci H, Nerad JA, Hassan AS. Periocular necrotizing fasciitis with visual loss: pathogenesis and treatment. Ophthalmology. 2006;113(12):2338&#8211;45.<pub-id pub-id-type="pmid">16996594</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.ophtha.2006.06.037</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR7"><label>7.</label><citation-alternatives><element-citation id="ec-CR7" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Amrith</surname><given-names>S</given-names></name><name name-style="western"><surname>HosdurgaPai</surname><given-names>V</given-names></name><name name-style="western"><surname>Ling</surname><given-names>WW</given-names></name></person-group><article-title>Periorbital necrotizing fasciitis&#8211;a review</article-title><source>Acta Ophthalmol</source><year>2013</year><volume>91</volume><issue>7</issue><fpage>596</fpage><lpage>603</lpage><pub-id pub-id-type="doi">10.1111/j.1755-3768.2012.02420.x</pub-id><pub-id pub-id-type="pmid">22520175</pub-id></element-citation><mixed-citation id="mc-CR7" publication-type="journal">Amrith S, HosdurgaPai V, Ling WW. Periorbital necrotizing fasciitis&#8211;a review. Acta Ophthalmol. 2013;91(7):596&#8211;603.<pub-id pub-id-type="pmid">22520175</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1111/j.1755-3768.2012.02420.x</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR8"><label>8.</label><citation-alternatives><element-citation id="ec-CR8" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Haque</surname><given-names>SA</given-names></name><name name-style="western"><surname>Georgiou</surname><given-names>A</given-names></name><name name-style="western"><surname>Henderson</surname><given-names>H</given-names></name><name name-style="western"><surname>Woollard</surname><given-names>A</given-names></name></person-group><article-title>Necrotizing fasciitis of the periorbital region: from presentation to reconstructive journey</article-title><source>Eur J Plast Surg</source><year>2021</year><volume>44</volume><fpage>531</fpage><lpage>536</lpage><pub-id pub-id-type="doi">10.1007/s00238-020-01743-8</pub-id><pub-id pub-id-type="pmid">32952307</pub-id><pub-id pub-id-type="pmcid">PMC7490476</pub-id></element-citation><mixed-citation id="mc-CR8" publication-type="journal">Haque SA, Georgiou A, Henderson H, Woollard A. Necrotizing fasciitis of the periorbital region: from presentation to reconstructive journey. Eur J Plast Surg. 2021;44:531&#8211;6.<pub-id pub-id-type="pmid">32952307</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s00238-020-01743-8</pub-id><pub-id pub-id-type="pmcid">PMC7490476</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR9"><label>9.</label><citation-alternatives><element-citation id="ec-CR9" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wong</surname><given-names>CH</given-names></name><name name-style="western"><surname>Khin</surname><given-names>LW</given-names></name><name name-style="western"><surname>Heng</surname><given-names>KS</given-names></name><name name-style="western"><surname>Tan</surname><given-names>KC</given-names></name><name name-style="western"><surname>Low</surname><given-names>CO</given-names></name></person-group><article-title>The LRINEC (Laboratory Risk Indicator for Necrotizing Fasciitis) score: a tool for distinguishing necrotizing fasciitis from other soft tissue infections</article-title><source>Crit Care Med</source><year>2004</year><volume>32</volume><issue>7</issue><fpage>1535</fpage><lpage>1541</lpage><pub-id pub-id-type="doi">10.1097/01.CCM.0000129486.35458.7D</pub-id><pub-id pub-id-type="pmid">15241098</pub-id></element-citation><mixed-citation id="mc-CR9" publication-type="journal">Wong CH, Khin LW, Heng KS, Tan KC, Low CO. The LRINEC (Laboratory Risk Indicator for Necrotizing Fasciitis) score: a tool for distinguishing necrotizing fasciitis from other soft tissue infections. Crit Care Med. 2004;32(7):1535&#8211;41.<pub-id pub-id-type="pmid">15241098</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1097/01.ccm.0000129486.35458.7d</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR10"><label>10.</label><citation-alternatives><element-citation id="ec-CR10" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tambe</surname><given-names>K</given-names></name><name name-style="western"><surname>Tripathi</surname><given-names>A</given-names></name><name name-style="western"><surname>Burns</surname><given-names>J</given-names></name><name name-style="western"><surname>Sampath</surname><given-names>R</given-names></name></person-group><article-title>Multidisciplinary management of periocular necrotising fasciitis: a series of 11 patients</article-title><source>Eye</source><year>2012</year><volume>26</volume><issue>3</issue><fpage>463</fpage><lpage>467</lpage><pub-id pub-id-type="doi">10.1038/eye.2011.241</pub-id><pub-id pub-id-type="pmid">22157919</pub-id><pub-id pub-id-type="pmcid">PMC3298976</pub-id></element-citation><mixed-citation id="mc-CR10" publication-type="journal">Tambe K, Tripathi A, Burns J, Sampath R. Multidisciplinary management of periocular necrotising fasciitis: a series of 11 patients. Eye. 2012;26(3):463&#8211;7.<pub-id pub-id-type="pmid">22157919</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/eye.2011.241</pub-id><pub-id pub-id-type="pmcid">PMC3298976</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR11"><label>11.</label><citation-alternatives><element-citation id="ec-CR11" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yii</surname><given-names>YC</given-names></name><name name-style="western"><surname>Hsieh</surname><given-names>VC</given-names></name><name name-style="western"><surname>Lin</surname><given-names>CL</given-names></name><name name-style="western"><surname>Wang</surname><given-names>YC</given-names></name><name name-style="western"><surname>Chen</surname><given-names>WK</given-names></name></person-group><article-title>Alcohol use disorder increases the risk of necrotizing fasciitis: a nationwide retrospective cohort study</article-title><source>Medicine</source><year>2017</year><volume>96</volume><issue>32</issue><fpage>e7509</fpage><pub-id pub-id-type="doi">10.1097/MD.0000000000007509</pub-id><pub-id pub-id-type="pmid">28796035</pub-id><pub-id pub-id-type="pmcid">PMC5556201</pub-id></element-citation><mixed-citation id="mc-CR11" publication-type="journal">Yii YC, Hsieh VC, Lin CL, Wang YC, Chen WK. Alcohol use disorder increases the risk of necrotizing fasciitis: a nationwide retrospective cohort study. Medicine. 2017;96(32):e7509.<pub-id pub-id-type="pmid">28796035</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1097/MD.0000000000007509</pub-id><pub-id pub-id-type="pmcid">PMC5556201</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR12"><label>12.</label><citation-alternatives><element-citation id="ec-CR12" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Pasala</surname><given-names>S</given-names></name><name name-style="western"><surname>Barr</surname><given-names>T</given-names></name><name name-style="western"><surname>Messaoudi</surname><given-names>I</given-names></name></person-group><article-title>Impact of alcohol abuse on the adaptive immune system</article-title><source>Alcohol Res</source><year>2015</year><volume>37</volume><issue>2</issue><fpage>185</fpage><pub-id pub-id-type="pmid">26695744</pub-id><pub-id pub-id-type="pmcid">PMC4590616</pub-id></element-citation><mixed-citation id="mc-CR12" publication-type="journal">Pasala S, Barr T, Messaoudi I. Impact of alcohol abuse on the adaptive immune system. Alcohol Res. 2015;37(2):185.<pub-id pub-id-type="pmid">26695744</pub-id><pub-id pub-id-type="pmcid">PMC4590616</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR13"><label>13.</label><citation-alternatives><element-citation id="ec-CR13" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Parlet</surname><given-names>CP</given-names></name><name name-style="western"><surname>Kavanaugh</surname><given-names>JS</given-names></name><name name-style="western"><surname>Horswill</surname><given-names>AR</given-names></name><name name-style="western"><surname>Schlueter</surname><given-names>AJ</given-names></name></person-group><article-title>Chronic ethanol feeding increases the severity of Staphylococcus aureus skin infections by altering local host defenses</article-title><source>J Leucocyte Biol</source><year>2015</year><volume>97</volume><issue>4</issue><fpage>769</fpage><lpage>778</lpage><pub-id pub-id-type="doi">10.1189/jlb.4A0214-092R</pub-id><pub-id pub-id-type="pmcid">PMC4370047</pub-id><pub-id pub-id-type="pmid">25605871</pub-id></element-citation><mixed-citation id="mc-CR13" publication-type="journal">Parlet CP, Kavanaugh JS, Horswill AR, Schlueter AJ. Chronic ethanol feeding increases the severity of Staphylococcus aureus skin infections by altering local host defenses. J Leucocyte Biol. 2015;97(4):769&#8211;78.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1189/jlb.4A0214-092R</pub-id><pub-id pub-id-type="pmcid">PMC4370047</pub-id><pub-id pub-id-type="pmid">25605871</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR14"><label>14.</label><citation-alternatives><element-citation id="ec-CR14" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Molina</surname><given-names>PE</given-names></name><name name-style="western"><surname>Sulzer</surname><given-names>JK</given-names></name><name name-style="western"><surname>Whitaker</surname><given-names>AM</given-names></name></person-group><article-title>Alcohol abuse and the injured host: dysregulation of counterregulatory mechanisms review</article-title><source>Shock</source><year>2013</year><volume>39</volume><issue>3</issue><fpage>240</fpage><lpage>249</lpage><pub-id pub-id-type="doi">10.1097/SHK.0b013e318285b86d</pub-id><pub-id pub-id-type="pmid">23416555</pub-id><pub-id pub-id-type="pmcid">PMC3672362</pub-id></element-citation><mixed-citation id="mc-CR14" publication-type="journal">Molina PE, Sulzer JK, Whitaker AM. Alcohol abuse and the injured host: dysregulation of counterregulatory mechanisms review. Shock. 2013;39(3):240&#8211;9.<pub-id pub-id-type="pmid">23416555</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1097/SHK.0b013e318285b86d</pub-id><pub-id pub-id-type="pmcid">PMC3672362</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR15"><label>15.</label><citation-alternatives><element-citation id="ec-CR15" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Nunn</surname><given-names>J</given-names></name><name name-style="western"><surname>Erdogan</surname><given-names>M</given-names></name><name name-style="western"><surname>Green</surname><given-names>RS</given-names></name></person-group><article-title>The prevalence of alcohol-related trauma recidivism: a systematic review</article-title><source>Injury</source><year>2016</year><volume>47</volume><issue>3</issue><fpage>551</fpage><lpage>558</lpage><pub-id pub-id-type="doi">10.1016/j.injury.2016.01.008</pub-id><pub-id pub-id-type="pmid">26830122</pub-id></element-citation><mixed-citation id="mc-CR15" publication-type="journal">Nunn J, Erdogan M, Green RS. The prevalence of alcohol-related trauma recidivism: a systematic review. Injury. 2016;47(3):551&#8211;8.<pub-id pub-id-type="pmid">26830122</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.injury.2016.01.008</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR16"><label>16.</label><citation-alternatives><element-citation id="ec-CR16" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Jeong</surname><given-names>J</given-names></name><name name-style="western"><surname>Song</surname><given-names>KJ</given-names></name><name name-style="western"><surname>Kim</surname><given-names>YJ</given-names></name><name name-style="western"><surname>Cho</surname><given-names>JS</given-names></name><name name-style="western"><surname>Park</surname><given-names>JO</given-names></name><name name-style="western"><surname>Lee</surname><given-names>SC</given-names></name><name name-style="western"><surname>Ro</surname><given-names>YS</given-names></name><name name-style="western"><surname>Holmes</surname><given-names>JF</given-names></name></person-group><article-title>The association between acute alcohol consumption and discharge against medical advice of injured patients in the ED</article-title><source>Am J Emerg Med</source><year>2016</year><volume>34</volume><issue>3</issue><fpage>464</fpage><lpage>468</lpage><pub-id pub-id-type="doi">10.1016/j.ajem.2015.11.065</pub-id><pub-id pub-id-type="pmid">26776298</pub-id></element-citation><mixed-citation id="mc-CR16" publication-type="journal">Jeong J, Song KJ, Kim YJ, Cho JS, Park JO, Lee SC, Ro YS, Holmes JF. The association between acute alcohol consumption and discharge against medical advice of injured patients in the ED. Am J Emerg Med. 2016;34(3):464&#8211;8.<pub-id pub-id-type="pmid">26776298</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.ajem.2015.11.065</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR17"><label>17.</label><citation-alternatives><element-citation id="ec-CR17" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sullivan</surname><given-names>JT</given-names></name><name name-style="western"><surname>Naranjo</surname><given-names>CA</given-names></name><name name-style="western"><surname>Sellers</surname><given-names>EM</given-names></name></person-group><article-title>Compliance among heavy alcohol users in clinical drug trials</article-title><source>J Subst Abuse</source><year>1988</year><volume>1</volume><issue>2</issue><fpage>183</fpage><lpage>194</lpage><pub-id pub-id-type="doi">10.1016/S0899-3289(88)80021-X</pub-id><pub-id pub-id-type="pmid">2980999</pub-id></element-citation><mixed-citation id="mc-CR17" publication-type="journal">Sullivan JT, Naranjo CA, Sellers EM. Compliance among heavy alcohol users in clinical drug trials. J Subst Abuse. 1988;1(2):183&#8211;94.<pub-id pub-id-type="pmid">2980999</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/s0899-3289(88)80021-x</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR18"><label>18.</label><citation-alternatives><element-citation id="ec-CR18" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cozzupoli</surname><given-names>GM</given-names></name><name name-style="western"><surname>Gui</surname><given-names>D</given-names></name><name name-style="western"><surname>Cozza</surname><given-names>V</given-names></name><name name-style="western"><surname>Lodoli</surname><given-names>C</given-names></name><name name-style="western"><surname>Pennisi</surname><given-names>MA</given-names></name><name name-style="western"><surname>Caporossi</surname><given-names>A</given-names></name><name name-style="western"><surname>Falsini</surname><given-names>B</given-names></name></person-group><article-title>Necrotizing fasciitis following herpes zoster ophthalmicus in an immunocompromised patient</article-title><source>Case Rep Ophthalmol Med</source><year>2019</year><volume>2019</volume><issue>1</issue><fpage>4534153</fpage><pub-id pub-id-type="pmid">30805235</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1155/2019/4534153</pub-id><pub-id pub-id-type="pmcid">PMC6360555</pub-id></element-citation><mixed-citation id="mc-CR18" publication-type="journal">Cozzupoli GM, Gui D, Cozza V, Lodoli C, Pennisi MA, Caporossi A, Falsini B. Necrotizing fasciitis following herpes zoster ophthalmicus in an immunocompromised patient. Case Rep Ophthalmol Med. 2019;2019(1):4534153.<pub-id pub-id-type="pmid">30805235</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1155/2019/4534153</pub-id><pub-id pub-id-type="pmcid">PMC6360555</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR19"><label>19.</label><mixed-citation publication-type="other">Can B, G&#246;zel B. Necrotizing fasciitis after herpes zoster infection: a rare case with diagnostic difficulties. Cureus. 2022 May;14(5)<pub-id pub-id-type="doi" assigning-authority="pmc">10.7759/cureus.24805</pub-id><pub-id pub-id-type="pmcid">PMC9169881</pub-id><pub-id pub-id-type="pmid">35686258</pub-id></mixed-citation></ref><ref id="CR20"><label>20.</label><citation-alternatives><element-citation id="ec-CR20" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>De Benedictis</surname><given-names>FM</given-names></name><name name-style="western"><surname>Osimani</surname><given-names>P</given-names></name></person-group><article-title>Necrotising fasciitis complicating varicella</article-title><source>Arch Dis Child</source><year>2008</year><volume>93</volume><issue>7</issue><fpage>619</fpage><pub-id pub-id-type="doi">10.1136/adc.2008.141994</pub-id><pub-id pub-id-type="pmid">18567772</pub-id></element-citation><mixed-citation id="mc-CR20" publication-type="journal">De Benedictis FM, Osimani P. Necrotising fasciitis complicating varicella. Arch Dis Child. 2008;93(7):619.<pub-id pub-id-type="pmid">18567772</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1136/adc.2008.141994</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR21"><label>21.</label><citation-alternatives><element-citation id="ec-CR21" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sewell</surname><given-names>GS</given-names></name><name name-style="western"><surname>Hsu</surname><given-names>VP</given-names></name><name name-style="western"><surname>Jones</surname><given-names>SR</given-names></name></person-group><article-title>Zoster gangrenosum: necrotizing fasciitis as a complication of herpes zoster</article-title><source>Am J Med</source><year>2000</year><volume>108</volume><issue>6</issue><fpage>520</fpage><lpage>521</lpage><pub-id pub-id-type="doi">10.1016/S0002-9343(99)00395-2</pub-id><pub-id pub-id-type="pmid">10866590</pub-id></element-citation><mixed-citation id="mc-CR21" publication-type="journal">Sewell GS, Hsu VP, Jones SR. Zoster gangrenosum: necrotizing fasciitis as a complication of herpes zoster. Am J Med. 2000;108(6):520&#8211;1.<pub-id pub-id-type="pmid">10866590</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/s0002-9343(99)00395-2</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR22"><label>22.</label><citation-alternatives><element-citation id="ec-CR22" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Balaggan</surname><given-names>KS</given-names></name><name name-style="western"><surname>Goolamali</surname><given-names>SI</given-names></name></person-group><article-title>Periorbital necrotising fasciitis after minor trauma</article-title><source>Graefes Arch Clin Exp Ophthalmol</source><year>2006</year><volume>244</volume><fpage>268</fpage><lpage>270</lpage><pub-id pub-id-type="doi">10.1007/s00417-005-0078-4</pub-id><pub-id pub-id-type="pmid">16041587</pub-id></element-citation><mixed-citation id="mc-CR22" publication-type="journal">Balaggan KS, Goolamali SI. Periorbital necrotising fasciitis after minor trauma. Graefes Arch Clin Exp Ophthalmol. 2006;244:268&#8211;70.<pub-id pub-id-type="pmid">16041587</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s00417-005-0078-4</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR23"><label>23.</label><citation-alternatives><element-citation id="ec-CR23" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Jarrett</surname><given-names>P</given-names></name><name name-style="western"><surname>Ha</surname><given-names>T</given-names></name><name name-style="western"><surname>Oliver</surname><given-names>F</given-names></name></person-group><article-title>Necrotizing fasciitis complicating disseminated cutaneous herpes zoster</article-title><source>Clin Exp Dermatol</source><year>1998</year><volume>23</volume><issue>2</issue><fpage>87</fpage><lpage>88</lpage><pub-id pub-id-type="doi">10.1046/j.1365-2230.1998.00318.x</pub-id><pub-id pub-id-type="pmid">9692314</pub-id></element-citation><mixed-citation id="mc-CR23" publication-type="journal">Jarrett P, Ha T, Oliver F. Necrotizing fasciitis complicating disseminated cutaneous herpes zoster. Clin Exp Dermatol. 1998;23(2):87&#8211;8.<pub-id pub-id-type="pmid">9692314</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1046/j.1365-2230.1998.00318.x</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR24"><label>24.</label><citation-alternatives><element-citation id="ec-CR24" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Becker</surname><given-names>M</given-names></name><name name-style="western"><surname>Zb&#228;ren</surname><given-names>P</given-names></name><name name-style="western"><surname>Hermans</surname><given-names>R</given-names></name><name name-style="western"><surname>Becker</surname><given-names>CD</given-names></name><name name-style="western"><surname>Marchal</surname><given-names>F</given-names></name><name name-style="western"><surname>Kurt</surname><given-names>AM</given-names></name><name name-style="western"><surname>Marre</surname><given-names>S</given-names></name><name name-style="western"><surname>R&#252;fenacht</surname><given-names>DA</given-names></name><name name-style="western"><surname>Terrier</surname><given-names>F</given-names></name></person-group><article-title>Necrotizing fasciitis of the head and neck: role of CT in diagnosis and management</article-title><source>Radiology</source><year>1997</year><volume>202</volume><issue>2</issue><fpage>471</fpage><lpage>476</lpage><pub-id pub-id-type="doi">10.1148/radiology.202.2.9015076</pub-id><pub-id pub-id-type="pmid">9015076</pub-id></element-citation><mixed-citation id="mc-CR24" publication-type="journal">Becker M, Zb&#228;ren P, Hermans R, Becker CD, Marchal F, Kurt AM, Marre S, R&#252;fenacht DA, Terrier F. Necrotizing fasciitis of the head and neck: role of CT in diagnosis and management. Radiology. 1997;202(2):471&#8211;6.<pub-id pub-id-type="pmid">9015076</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1148/radiology.202.2.9015076</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR25"><label>25.</label><citation-alternatives><element-citation id="ec-CR25" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wysoki</surname><given-names>MG</given-names></name><name name-style="western"><surname>Santora</surname><given-names>TA</given-names></name><name name-style="western"><surname>Shah</surname><given-names>RM</given-names></name><name name-style="western"><surname>Friedman</surname><given-names>AC</given-names></name></person-group><article-title>Necrotizing fasciitis: CT characteristics</article-title><source>Radiology</source><year>1997</year><volume>203</volume><issue>3</issue><fpage>859</fpage><lpage>863</lpage><pub-id pub-id-type="doi">10.1148/radiology.203.3.9169717</pub-id><pub-id pub-id-type="pmid">9169717</pub-id></element-citation><mixed-citation id="mc-CR25" publication-type="journal">Wysoki MG, Santora TA, Shah RM, Friedman AC. Necrotizing fasciitis: CT characteristics. Radiology. 1997;203(3):859&#8211;63.<pub-id pub-id-type="pmid">9169717</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1148/radiology.203.3.9169717</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR26"><label>26.</label><citation-alternatives><element-citation id="ec-CR26" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zacharias</surname><given-names>N</given-names></name><name name-style="western"><surname>Velmahos</surname><given-names>GC</given-names></name><name name-style="western"><surname>Salama</surname><given-names>A</given-names></name><name name-style="western"><surname>Alam</surname><given-names>HB</given-names></name><name name-style="western"><surname>De Moya</surname><given-names>M</given-names></name><name name-style="western"><surname>King</surname><given-names>DR</given-names></name><name name-style="western"><surname>Novelline</surname><given-names>RA</given-names></name></person-group><article-title>Diagnosis of necrotizing soft tissue infections by computed tomography</article-title><source>Arch Surg</source><year>2010</year><volume>145</volume><issue>5</issue><fpage>452</fpage><lpage>455</lpage><pub-id pub-id-type="doi">10.1001/archsurg.2010.50</pub-id><pub-id pub-id-type="pmid">20479343</pub-id></element-citation><mixed-citation id="mc-CR26" publication-type="journal">Zacharias N, Velmahos GC, Salama A, Alam HB, De Moya M, King DR, Novelline RA. Diagnosis of necrotizing soft tissue infections by computed tomography. Arch Surg. 2010;145(5):452&#8211;5.<pub-id pub-id-type="pmid">20479343</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1001/archsurg.2010.50</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR27"><label>27.</label><citation-alternatives><element-citation id="ec-CR27" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Saldana</surname><given-names>M</given-names></name><name name-style="western"><surname>Gupta</surname><given-names>D</given-names></name><name name-style="western"><surname>Khandwala</surname><given-names>M</given-names></name><name name-style="western"><surname>Weir</surname><given-names>R</given-names></name><name name-style="western"><surname>Beigi</surname><given-names>B</given-names></name></person-group><article-title>Periorbital necrotizing fasciitis: outcomes using a CT-guided surgical debridement approach</article-title><source>Eur J Ophthalmol</source><year>2010</year><volume>20</volume><issue>1</issue><fpage>209</fpage><lpage>214</lpage><pub-id pub-id-type="doi">10.1177/112067211002000129</pub-id><pub-id pub-id-type="pmid">19882528</pub-id></element-citation><mixed-citation id="mc-CR27" publication-type="journal">Saldana M, Gupta D, Khandwala M, Weir R, Beigi B. Periorbital necrotizing fasciitis: outcomes using a CT-guided surgical debridement approach. Eur J Ophthalmol. 2010;20(1):209&#8211;14.<pub-id pub-id-type="pmid">19882528</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1177/112067211002000129</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR28"><label>28.</label><citation-alternatives><element-citation id="ec-CR28" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Luksich</surname><given-names>JA</given-names></name><name name-style="western"><surname>Holds</surname><given-names>JB</given-names></name><name name-style="western"><surname>Hartstein</surname><given-names>ME</given-names></name></person-group><article-title>Conservative management of necrotizing fasciitis of the eyelids</article-title><source>Ophthalmology</source><year>2002</year><volume>109</volume><issue>11</issue><fpage>2118</fpage><lpage>2122</lpage><pub-id pub-id-type="doi">10.1016/S0161-6420(02)01257-5</pub-id><pub-id pub-id-type="pmid">12414425</pub-id></element-citation><mixed-citation id="mc-CR28" publication-type="journal">Luksich JA, Holds JB, Hartstein ME. Conservative management of necrotizing fasciitis of the eyelids. Ophthalmology. 2002;109(11):2118&#8211;22.<pub-id pub-id-type="pmid">12414425</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/s0161-6420(02)01257-5</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR29"><label>29.</label><citation-alternatives><element-citation id="ec-CR29" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mehta</surname><given-names>R</given-names></name><name name-style="western"><surname>Kumar</surname><given-names>A</given-names></name><name name-style="western"><surname>Crock</surname><given-names>C</given-names></name><name name-style="western"><surname>McNab</surname><given-names>A</given-names></name></person-group><article-title>Medical management of periorbital necrotising fasciitis</article-title><source>Orbit</source><year>2013</year><volume>32</volume><issue>4</issue><fpage>253</fpage><lpage>255</lpage><pub-id pub-id-type="doi">10.3109/01676830.2013.788667</pub-id><pub-id pub-id-type="pmid">23663166</pub-id></element-citation><mixed-citation id="mc-CR29" publication-type="journal">Mehta R, Kumar A, Crock C, McNab A. Medical management of periorbital necrotising fasciitis. Orbit. 2013;32(4):253&#8211;5.<pub-id pub-id-type="pmid">23663166</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3109/01676830.2013.788667</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR30"><label>30.</label><citation-alternatives><element-citation id="ec-CR30" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mutamba</surname><given-names>A</given-names></name><name name-style="western"><surname>Verity</surname><given-names>DH</given-names></name><name name-style="western"><surname>Rose</surname><given-names>GE</given-names></name></person-group><article-title>&#8216;Stalled&#8217;periocular necrotising fasciitis: early effective treatment or host genetic determinants?</article-title><source>Eye</source><year>2013</year><volume>27</volume><issue>3</issue><fpage>432</fpage><lpage>437</lpage><pub-id pub-id-type="doi">10.1038/eye.2012.285</pub-id><pub-id pub-id-type="pmid">23412558</pub-id><pub-id pub-id-type="pmcid">PMC3597886</pub-id></element-citation><mixed-citation id="mc-CR30" publication-type="journal">Mutamba A, Verity DH, Rose GE. &#8216;Stalled&#8217;periocular necrotising fasciitis: early effective treatment or host genetic determinants? Eye. 2013;27(3):432&#8211;7.<pub-id pub-id-type="pmid">23412558</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/eye.2012.285</pub-id><pub-id pub-id-type="pmcid">PMC3597886</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR31"><label>31.</label><citation-alternatives><element-citation id="ec-CR31" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hofmaenner</surname><given-names>DA</given-names></name><name name-style="western"><surname>Wendel Garcia</surname><given-names>PD</given-names></name><name name-style="western"><surname>Blum</surname><given-names>MR</given-names></name><name name-style="western"><surname>David</surname><given-names>S</given-names></name><name name-style="western"><surname>Schuepbach</surname><given-names>RA</given-names></name><name name-style="western"><surname>Buehler</surname><given-names>PK</given-names></name><name name-style="western"><surname>Frey</surname><given-names>PM</given-names></name><name name-style="western"><surname>Zinkernagel</surname><given-names>AS</given-names></name><name name-style="western"><surname>Brugger</surname><given-names>SD</given-names></name></person-group><article-title>The importance of intravenous immunoglobulin treatment in critically ill patients with necrotizing soft tissue infection: a retrospective cohort study</article-title><source>BMC Infect Dis</source><year>2022</year><volume>22</volume><issue>1</issue><fpage>168</fpage><pub-id pub-id-type="doi">10.1186/s12879-022-07135-6</pub-id><pub-id pub-id-type="pmid">35189821</pub-id><pub-id pub-id-type="pmcid">PMC8862556</pub-id></element-citation><mixed-citation id="mc-CR31" publication-type="journal">Hofmaenner DA, Wendel Garcia PD, Blum MR, David S, Schuepbach RA, Buehler PK, Frey PM, Zinkernagel AS, Brugger SD. The importance of intravenous immunoglobulin treatment in critically ill patients with necrotizing soft tissue infection: a retrospective cohort study. BMC Infect Dis. 2022;22(1):168.<pub-id pub-id-type="pmid">35189821</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1186/s12879-022-07135-6</pub-id><pub-id pub-id-type="pmcid">PMC8862556</pub-id></mixed-citation></citation-alternatives></ref></ref-list></back></article></pmc-articleset>